Supplemental material
Modern Rheumatology
Volume 30, 2020 - Issue 1
Related Research Data
Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database.
Source:
Informa Healthcare
RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report
Source:
Taylor & Francis
Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose
Source:
Oxford University Press (OUP)
The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis
Source:
Oxford University Press (OUP)
RECORD LINKAGE TO CONDUCT AN EPIDEMIOLOGIC STUDY ON THE ASSOCIATION OF RHEUMATOID ARTHRITIS AND LYMPHOMA IN THE PROVINCE OF SASKATCHEWAN, CANADA
Source:
Elsevier BV
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Source:
Oxford University Press (OUP)
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
Source:
The Journal of Rheumatology
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Source:
Oxford University Press (OUP)
Therapeutic criteria in rheumatoid arthritis.
Source:
American Medical Association (AMA)
Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report
Source:
Taylor & Francis
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
Source:
Informa UK Limited
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Source:
Oxford University Press (OUP)
Rheumatoid arthritis and cancer risk.
Source:
Elsevier BV
Linking provided by
